Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brenda Cooperstone currently holds 62,500 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brenda Cooperstone has been a net neutral trader of LXEO stock. They have purchased $0 and sold $0 worth of shares.
Brenda Cooperstone's most recent insider trade was on Jul 10, 2024, when they sold 62,500 shares at $0.00 per share.
Brenda Cooperstone serves as Executive at Lexeo Therapeutics, Inc. (LXEO). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Brenda Cooperstone holds the position of Executive at Lexeo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Brenda Cooperstone has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Brenda Cooperstone was on Jul 10, 2024, when they purchased $0 worth of SNTI shares. This transaction involved 62,500 shares at N/A per share.
Brenda Cooperstone currently owns 62,500 shares of Lexeo Therapeutics, Inc. (LXEO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brenda Cooperstone's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brenda Cooperstone has 2 Form 4 filings on record as an insider at Lexeo Therapeutics, Inc..
Set alerts for Brenda Cooperstone and 40,000+ other insiders.